Ligand Pharmaceuticals LGND Short-term portion of financial royalty assets, net
Short-term portion of financial royalty assets, net at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept lgnd:FinancialRoyaltyAssetsCurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's short-term portion of financial royalty assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's short-term portion of financial royalty assets, net?
- Ligand Pharmaceuticals (LGND) reported short-term portion of financial royalty assets, net of $12.15M in Q1 2026.
- What does short-term portion of financial royalty assets, net mean?
- This represents the portion of royalty-based financial assets expected to be realized or collected within one year. It reflects the near-term cash flow potential derived from the company's intellectual property licensing agreements. Monitoring this helps assess the liquidity provided by the company's core royalty-generating business model.